Newsroom

SINGAPORE--(BUSINESS WIRE)--Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stabi...

SINGAPORE--(BUSINESS WIRE)--AM Best is maintaining a stable outlook on Malaysia’s non-life insurance segment, citing regulatory initiatives designed to increase insurance penetration and phased de-tariffication of motor and fire insurance. The Best’s Market Segment Report, “Market Segment Outlook: Malaysia Non-Life Insurance,” states that the non-life sector remains well-positioned for continued growth, even as the country’s real GDP growth is forecast to moderate in the near term amid global e...

PALO ALTO, California--(BUSINESS WIRE)--HTEC, provider globale di servizi di progettazione e ingegneria software e hardware, oggi ha pubblicato il documento "The State of AI in Financial Services & Insurance 2025" (Lo stato dell'intelligenza artificiale nei servizi finanziari e assicurativi 2025), un primo capitolo, dedicato al settore, nella relazione di ricerca globale sull'AI a cura dell'azienda. La pubblicazione offre una delle panoramiche a tutt'oggi più chiare sul modo in cui le istit...

PALO ALTO, Californie--(BUSINESS WIRE)--HTEC, un fournisseur mondial de services de conception et d’ingénierie de logiciels et de matériel axé sur l'IA, publie aujourd’hui The State of AI in Financial Services & Insurance 2025, un premier sous-ensemble de son rapport de recherche mondial sur l’IA. Cette publication offre l'un des points de vue les plus lucides à ce jour sur la façon dont les établissements financiers adoptent et déploient l'intelligence artificielle. Ce rapport axé sur l’in...

PALO ALTO, Kalifornien--(BUSINESS WIRE)--HTEC, ein globaler AI-First-Anbieter von Software- und Hardware-Design- und Engineering-Dienstleistungen, hat heute The State of AI in Financial Services & Insurance 2025 veröffentlicht, einen ersten Branchenauszug aus seinem globalen Forschungsbericht zum Thema KI. Diese Publikation bietet einen der bislang klarsten Einblicke in die Art und Weise, wie Finanzinstitute künstliche Intelligenz einsetzen und skalieren. Dieser branchenorientierte Bericht...

PALO ALTO, Calif.--(BUSINESS WIRE)--HTEC, een wereldwijde AI-first leverancier van software- en hardwareontwerp- en engineeringdiensten, heeft vandaag The State of AI in Financial Services & Insurance 2025 gepubliceerd, een eerste branchegerichte subset van zijn wereldwijde onderzoeksrapport over AI. Deze publicatie biedt een van de duidelijkste inzichten tot nu toe in hoe financiële instellingen kunstmatige intelligentie toepassen en opschalen. Dit branchegerichte rapport analyseert inzich...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Generation Bio Co. (NASDAQ: GBIO) to XOMA Royalty Corporation for $4.2913 per share and one non-transferable contingent value right per share entitling holders to receive potential payments under certain conditions is fair to Generation Bio shareholders. Halper Sadeh encourages Generation Bio shareholders to click here to learn more about their legal rights and options or contact Danie...

PALO ALTO, California--(BUSINESS WIRE)--HTEC, proveedor global de servicios de diseño y de ingeniería de software y hardware con enfoque prioritario en inteligencia artificial, publicó hoy The State of AI in Financial Services & Insurance 2025, el primer subconjunto sectorial de su informe global sobre IA. Esta publicación ofrece una de las perspectivas más claras hasta la fecha sobre cómo las instituciones financieras están adoptando y ampliando la inteligencia artificial. El informe secto...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for the reproxalap New Drug Application (NDA) for the treatment of dry eye disease. The extended PDUFA target action date is March 16, 2026. Fol...

ATHÈNES, Grèce--(BUSINESS WIRE)--  COMMUNIQUÉ DESTINÉ UNIQUEMENT AUX MÉDIAS EUROPÉENS SPÉCIALISÉS DANS LES DOMAINES MÉDICAL, PHARMACEUTIQUE ET FINANCIER Genesis Pharma, société biopharmaceutique régionale spécialisée dans la commercialisation de médicaments innovants en Europe centrale et orientale, a annoncé la signature d'un accord de distribution exclusive avec Otsuka Pharmaceutical Europe Ltd. (OPEL), filiale européenne du groupe pharmaceutique mondial Otsuka Pharmaceutical Co., Ltd., conce...